Table A, Pharmacologic agents used in the treatment of gout
Paul G Shekelle(VA Greater Los Angeles Healthcare System), Marika Booth(RAND Corporation), John FitzGerald(California Digital Library), Roberta Shanman(RAND Corporation), Abdul Tariq(VA Greater Los Angeles Healthcare System), Adeyemi Okunogbe(RAND Corporation), Claire E O’Hanlon(RAND Corporation), Dan Han(Zhejiang University), Aneesa Motala(University of Southern California), Sydne J Newberry, Whitney Dudley
Unknown
March 1, 2016
Cited by 0
Related Papers
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
|Circulation Research|2020|767
Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated?
|PubMed|2001|599
Economic impacts of overweight and obesity: current and future estimates for eight countries
|BMJ Global Health|2021|363
The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis
|Systematic Reviews|2014|343
Patients' Global Ratings of Their Health Care Are Not Associated with the Technical Quality of Their Care
|Annals of Internal Medicine|2006|294